Related references
Note: Only part of the references are listed.Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
Ju-Hwa Kim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of Salinomycin on Cancer Stem Cell in Human Lung Adenocarcinoma A549 Cells
Yi Wang
MEDICINAL CHEMISTRY (2011)
Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression
Sin Ho Kweon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
Dominik Fuchs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Jnk signaling pathway-mediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines
Ju-Hwa Kim et al.
BIOCHEMICAL PHARMACOLOGY (2010)
The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
Roberta Riccioni et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Kitlow Stem Cells Cause Resistance to Kit/Platelet-Derived Growth Factor α Inhibitors in Murine Gastrointestinal Stromal Tumors
Michael R. Bardsley et al.
GASTROENTEROLOGY (2010)
Human papillomavirus 16 E6 increases the radiosensitivity of p53-mutated cervical cancer cells, associated with up-regulation of aurora A
Hye-Jin Shin et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2010)
Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer
Chang Gong et al.
PLOS ONE (2010)
SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin
Ju-Hwa Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells
Dominik Fuchs et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
A Single Recombinant Adenovirus Expressing p53 and p21-targeting Artificial microRNAs Efficiently Induces Apoptosis in Human Cancer Cells
Masashi Idogawa et al.
CLINICAL CANCER RESEARCH (2009)
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis
Eun-Woo Lee et al.
EMBO JOURNAL (2009)
Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study
Peter D. Inskip et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Death Receptor-Induced Activation of the Chk2-and Histone H2AX-Associated DNA Damage Response Pathways
Stephanie Solier et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers
See-Hyoung Park et al.
CANCER BIOLOGY & THERAPY (2008)
Development of inhibitors of ATP-binding cassette drug transporters - present status and challenges
Suneet Shukla et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Increased cytoplasmic levels of CIS, SOCS1, SOCS2, or SOCS3 are required for nuclear translocation
Kyeong-Hee Lee et al.
FEBS LETTERS (2008)
P-TEFb inhibitors interfere with activation of p53 by DNA-damaging agents
S. K. Radhakrishnan et al.
ONCOGENE (2008)
Reversal of multidrug resistance by 4-chloro-N-(3-((E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)phenyl)benzamide through the reversible inhibition of P-glycoprotein
Yong Kee Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening
N Mahmoudi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell lines
AL Dogan et al.
LEUKEMIA RESEARCH (2004)
P21 (Waf1/Cip1) as a therapeutic target in breast and other cancers
RH Weiss
CANCER CELL (2003)
Share Paper
